Nexxt Spine said today it won FDA 510(k) clearance for its Nexxt Matrixx platform of interbody and vertebral body replacement devices.
The Noblesville, Ind.-based company said the Nexxt Matrixx system is composed of porous titanium devices designed with open architectural porosity, residue-free surface tech and “robust radiographic imaging performance.”
“The Nexxt Matrixx system applies breakthrough technology to our company’s product portfolio and surgeon response has been overwhelmingly positive. We will continue to expand our Nexxt Matrixx offering throughout 2017 and into 2018 to ensure this differentiated technology is available for all spinal fusion surgical approaches,” prez Andy Elsbury said in a prepared statement.
Nexxt Spine said that previous studies have shown that textured titanium alloy surfaces produce positive bone responses, including increases in osteoblast differentiation and surface osteointegration when compared to smooth surfaces.